China, Sanofi

Sanofi announces its biggest China investment deal amid China-EU trade tensions
Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will mark the French drugmaker's largest single investment in China, the company said on Monday.
Sanofi Unveils $1 Billion China Investment to Boost Production
Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest single investment in China to date and part of a broader push to boost manufacturing capacity in Asia.
Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China
The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of insulin, focusing on serving local diabetic patients.
Sanofi to invest in new insulin production base in Beijing
French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in Beijing, according to the Beijing Economic-Technological Development Area (BDA).
China welcomes new US$1 billion Sanofi project in Beijing
Chinese authorities rolled out the red carpet for French pharmaceutical and healthcare giant Sanofi, which plans to invest around 1 billion euros (US$1.05 billion) to build a new insulin plant in Beijing - the company's single biggest capital outlay in the world's second-largest economy.
Sanofi charts biggest China investment to date with plans for €1B insulin 'manufacturing base' in Beijing
Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing outlay in China, marking its biggest investment in the country to date. | Sanofi is laying out roughly 1 billion euros ($1.
Sanofi announces its largest China investment amid ongoing trade war
The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer on.
Sanofi punts 1 billion euros on new insulin production base in China
The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing Municipal Bureau of Economy and Information Technology and Beijing Economic and Technological Development Zone today to invest around 1 billion euros ($1.
Sanofi invests 1 bln euros in Beijing to expand insulin production
Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health
Sanofi To Invest $1.05 Bln For New Insulin Production Base In China
French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in
STAT19h
Sanofi pours $1 billion into China for insulin plant
Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...
academy23m
China's First International Pharma
The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...